Pushkar Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.46 M
as on 05-01-2025
- Paid Up Capital ₹ 1.48 M
as on 05-01-2025
- Company Age 31 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.58 M
as on 05-01-2025
- Revenue 68.90%
(FY 2022)
- Profit -122.13%
(FY 2022)
- Ebitda 99.79%
(FY 2022)
- Net Worth -0.31%
(FY 2022)
- Total Assets -0.23%
(FY 2022)
About Pushkar Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.46 M and a paid-up capital of Rs 1.48 M.
The company currently has active open charges totaling ₹9.58 M.
Neel Sharma and Chander Pushkarna serve as directors at the Company.
- CIN/LLPIN
U24231CH1993PTC013103
- Company No.
013103
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Mar 1993
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- LocationU T, Chandigarh
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Pushkar Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neel Sharma  | Director | 03-Mar-1993 | Current |
| Chander Pushkarna | Director | 03-Mar-1993 | Current |
Financial Performance of Pushkar Pharmaceuticals.
Pushkar Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 68.9% increase. The company also saw a substantial fall in profitability, with a 122.13% decrease in profit. The company's net worth dipped by a decrease of 0.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pushkar Pharmaceuticals?
In 2021, Pushkar Pharmaceuticals had a promoter holding of 35.21% and a public holding of 64.79%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Kala- Amb Infrastructure Development CompanyActive 13 years 11 months
Chander Pushkarna is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 26 Jun 1996 | ₹5.83 M | Open |
The Haryana Financial Corp. Creation Date: 18 Apr 1996 | ₹1.08 M | Open |
Canara Bank Creation Date: 31 Mar 1995 | ₹0.80 M | Open |
How Many Employees Work at Pushkar Pharmaceuticals?
Unlock and access historical data on people associated with Pushkar Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pushkar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pushkar Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
